Published: March 28, 2022, 7 a.m.
                        
Tackle the complex pathophysiology, diagnosis, and management of hepatorenal syndrome in this Curbsiders classic from #NephMadness 2019 featuring @kidney_boy Joel Topf, HRS expert Juan Carlos Velez (@veleznephhepato), and self-proclaimed most-handsome-nephrologist Bill Whittier (@TWhittier_RUSH) episode! Topics: hepatorenal physiology, renal ultrasound, urine electrolytes, terlipressin, norepinephrine, midodrine and octreotide, albumin challenge, crystalloids vs colloids, and more! Original show notes here.\n
\n\n\nShow Notes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | Free CME!\n\n\n
\n
\nCredits\n\n
\n- Written and produced by: Justin Berk MD, Nora Taranto MD
 \n- Infographic by: Alex M @nephroguy\n
 \n- Host: Matthew Watto MD
 \n- Edited by: Matthew Watto MD (audio), Emi Okamoto MD (written materials)
 \n- Guests: Joel Topf MD, Juan Carlos Velez MD, Bill Whittier MD
\n
\n\n \n
\n
Show Segments\n
\n- NephMadness Kidney Pun Contest
 \n- Disclaimer
 \n- Intro, guest one-liners
 \n- Case of acute kidney injury in a patient with cirrhosis
 \n- Initial differential diagnosis and approach to newly elevated creatinine in cirrhosis (urinalysis, FeNa, urine sodium)
 \n- History and physical in cirrhosis and AKI
 \n- Fluid choice
 \n- Diuretic therapy in cirrhosis and volume overload
 \n- Is a Renal Ultrasound useful in AKI?
 \n- Recap: the initial approach to AKI in cirrhosis
 \n- Therapeutic trials when volume status is uncertain
 \n- Hepatorenal physiology revisited
 \n- Vasoconstrictor therapy with octreotide, terlipressin, or norepinephrine
 \n- Type 1 versus type 2 hepatorenal syndrome
 \n- Large-volume paracentesis (LVP) in cirrhosis with AKI; how much fluid to remove; use of diuretics or LVP in patients on norepinephrine?!
 \n- Diagnostic criteria or HRS
 \n- NephMadness matchups including bile cast nephropathy
 \n- Outro
 \n
\n
\nSponsors\xa0\n